Concepedia

Raymond M. Shaheen

RM

14

Publications

2.2K

Citations

14

H-Index

1996

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Society of Surgical Oncology

Raymond M. Shaheen is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and angiogenesis.

Top concepts

Publications per year

1996–2001

14

Publications

14

Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis.

Raymond M. Shaheen, Darren W. Davis, Wenbiao Liu et al. · PubMed · 1999 · 337 citations

, , +17

Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.

Dirk B. Mendel, Alexander Laird, Beverly D. Smolich et al. · PubMed · 2000 · 234 citations

, , +14

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

Raymond M. Shaheen, Syed A. Ahmad, W. Liu et al. · British Journal of Cancer · 2001 · 232 citations · Full text

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival

Niels Reinmuth, Wenbiao Liu, Young Do Jung et al. · The FASEB Journal · 2001 · 216 citations

The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer.

Syed A. Ahmad, Wenbiao Liu, Young Do Jung et al. · PubMed · 2001 · 211 citations

, , +15

Rows per page

1–5 of 14